Stefan Oelrich

Stability in Motion

Amid global uncertainty, Bayer Pharma, led by Stefan Oelrich, pursues strategic transformation to boost resilience, drive innovation, and secure sustainable growth in a changing healthcare landscape.

Top-Feature

Bio-Rad Laboratories

Anchored in Sustainability

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Bayer AG

Stefan Oelrich

Stability in Motion

Top-Feature

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

20 Years of CHEManager International

Leading Transformation

API Manufacturing

Brenntag Downsizes Management Board, Retains Both Divisions

Leading the way. Driving results.

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Driving Sustainability Through Collaboration

Anchored in Sustainability

Interview

Leading Transformation

Newsletter & e-edition